Bioreactors Market Size - Industry Report on Share, Growth Trends & Forecasts Analysis (2025 - 2030)

The Report Covers Global Bioreactors in Pharmaceutical Industry and the Market Segmented by Type (Glass, Stainless Steel, And Single-Use), Usage (Lab-Scale Production, Pilot-scale Production, And Full-Scale Production), Scale (5L-20L, 20l-200l, 200l-1, 500l, And Above 1, 500l), Control (Manual and Automated), And Geography (North America, Europe, Asia-pacific, Middle East and Africa, And South America). The Report Offers the Value (in USD Million) for the Above Segments.

Bioreactors Market Size - Industry Report on Share, Growth Trends & Forecasts Analysis (2025 - 2030)

Bioreactors Market Size

Bioreactor Market Summary
Study Period 2021 - 2030
Base Year For Estimation 2024
Market Size (2025) USD 5.71 Billion
Market Size (2030) USD 8.17 Billion
CAGR (2025 - 2030) 7.45 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Bioreactor Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Bioreactor Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Bioreactors Market Analysis

The Bioreactor Market size is estimated at USD 5.71 billion in 2025, and is expected to reach USD 8.17 billion by 2030, at a CAGR of 7.45% during the forecast period (2025-2030).

Bioreactors in the pharmaceutical industry have great potential uses in the development of vaccines and other pharmaceutical products that are being used to mitigate the spread of COVID-19 across the world. The high demand from governmental vaccination programs and private entities to vaccinate large sections of the population requires scientists to work under pressure to shorten the time-to-market of developed vaccines. This has created a huge demand in the Bioreactor industry from the biopharmaceutical and biotechnology sectors during the early phase of the pandemic. According to an article published by Frontiers in August 2022, Cell culture bioreactors were widely used in viral vaccine production during the COVID-19 pandemic, and the development and application of bioreactors provided more efficient and cost-effective vaccine production to meet the global vaccine demand. Thus, COVID-19 had a positive impact on the Global bioreactors market initially. However, currently, the market growth slowed down as the pandemic subsided, and it is expected to witness stable growth during the forecast period of the study.

Factors such as the growth of bioreactors in pharmaceuticals, technological advancements, and adoption of single-use bioreactors (SUBs) and hybrid bioreactors are the prime drivers of the Bioreactors market currently.

Biopharmaceuticals are utilized in a range of applications, from being in the production of biopharmaceuticals to applications in tissue engineering, such as cell expansion and generation of 3D tissue constructs. Bioreactors in the pharmaceutical industry are used to provide a controllable environment, in terms of pH, temperature, nutrient supply, and shear stress for any cells or cellular constructs incorporated into them. For instance, according to an article published by PubMed Central in February 2022, bioreactors allow production to be increased to industrial scales, which can quickly and cheaply produce large amounts of secondary metabolites and recombinant proteins in a short time. Bioreactors have been utilized in many different areas of industry and research, including Microbial fermentation and the progression of in vitro models of 2D cultures and suspensions to 3D constructs, mimicking the natural physiological state in situ. They have also proven to be crucial medicines that are used in autoimmune disorders, cancer, asthma, and organ rejection. Thus, the growth of bioreactors, including those in the Medical bioreactor market, is a major factor augmenting the growth of the market.

Furthermore, technological advancements in bioreactors and fermenters have improved the flexibility, quality, and scalability of operations with low capital and energy requirements. These innovations in Upstream bioprocessing methods and analytical tools are projected to enhance process robustness, accelerate scale-up to industrial production, and drive the efficient use of resources. The extensive use of hybrid bioreactor technology in effective waste management has also further accelerated the expansion of the market.

Initiatives by major Bioreactor manufacturers are also boosting the market growth. For instance, in May 2021, Beckman Coulter Life Sciences launched its next-generation Biolector XT Microbioreactor in Germany. The BioLector XT Microbioreactor allows cultivation parameter monitoring, high-throughput strain screenings, and feeding strategy optimization.

Thus, owing to the benefits offered by bioreactor technology and its increasing applications, the Bioreactors market is expected to witness significant growth over the forecast period. However, concerns regarding the use of single-use bioreactors and limited storage capacity can hamper the market growth.

Bioreactors Industry Overview

The Bioreactor market is moderately fragmented and consists of several major players. In terms of market share, a few of the major players currently dominate the market. However, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new products at lower prices. Companies like Sartorius AG, Thermo Fisher Scientific Inc., Pall Corporation (Danaher Corporation), and Eppendorf AG, leading Bioreactor manufacturers and Bioreactor brands, hold a significant market share in the Bioreactors market.

Bioreactors Market Leaders

  1. GE Healthcare

  2. Merck KGaA

  3. Eppendorf AG

  4. Sartorius AG

  5. Thermo Fisher Scientific Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Picture24.png
Need More Details on Market Players and Competiters?
Download PDF

Bioreactors Market News

  • October 2022: Getinge AB announced that their bioreactors will support the Dutch government's initiative to produce animal products such as meat and milk proteins directly from animal and microbial cells.
  • May 2022: Pall Corporation announced that its ICELL is a nano bioreactor that helped the Institute of Biomedicine of Seville (IBIS) to develop viral vectors for CAR-T therapy.

Bioreactors Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growth of Bioreactors in Pharmaceuticals
    • 4.2.2 Technological Advancements in Bioreactors
    • 4.2.3 Adoption of Single-use bioreactors (SUBs) and Hybrid Bioreactors
  • 4.3 Market Restraints
    • 4.3.1 Concerns Regarding the Use of Single-use Bioreactors (SUBs)
    • 4.3.2 Limited Storage Capacity
  • 4.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 By Type
    • 5.1.1 Glass
    • 5.1.2 Stainless Steel
    • 5.1.3 Single-use
  • 5.2 By Usage
    • 5.2.1 Lab-scale Production
    • 5.2.2 Pilot-scale Production
    • 5.2.3 Full-scale Production
  • 5.3 By Scale
    • 5.3.1 5L-20L
    • 5.3.2 20L-200L
    • 5.3.3 200L-1,500L
    • 5.3.4 Above 1,500L
  • 5.4 By Control Type
    • 5.4.1 Manual
    • 5.4.2 Automated (MFCs)
  • 5.5 By Geography
    • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
    • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
    • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 GE Healthcare
    • 6.1.2 Merck KGaA
    • 6.1.3 Eppendorf AG
    • 6.1.4 Sartorius AG
    • 6.1.5 Pall Corporation (Danaher Corporation)
    • 6.1.6 Getinge AB
    • 6.1.7 Bioengineering AG
    • 6.1.8 Infors HT
    • 6.1.9 Solida Biotech GmBH
    • 6.1.10 Solaris Biotech
    • 6.1.11 Thermo Fisher Scientific Inc.
    • 6.1.12 Esco Lifesciences Group Ltd
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Bioreactors Industry Segmentation

As per the scope of the report, bioreactors are large vessels used in industries that provide optimum conditions for the growth of microorganisms to carry out the biochemical process. They are used to speed up biochemical processes, such as fermentation and antibiotic drug production, where bacteria or yeast are added as inoculum to carry out the reaction. The bioreactor market is segmented by type (glass, stainless steel, and single-use), usage (lab-scale production, pilot-scale production, and full-scale production), scale (5L-20L, 20L-200L, 200L-1,500L, and above 1,500L), control (manual and automated), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments. The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally.

By Type Glass
Stainless Steel
Single-use
By Usage Lab-scale Production
Pilot-scale Production
Full-scale Production
By Scale 5L-20L
20L-200L
200L-1,500L
Above 1,500L
By Control Type Manual
Automated (MFCs)
By Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Bioreactors Market Research FAQs

How big is the Bioreactor Market?

The Bioreactor Market size is expected to reach USD 5.71 billion in 2025 and grow at a CAGR of 7.45% to reach USD 8.17 billion by 2030.

What is the current Bioreactor Market size?

In 2025, the Bioreactor Market size is expected to reach USD 5.71 billion.

Who are the key players in Bioreactor Market?

GE Healthcare, Merck KGaA, Eppendorf AG, Sartorius AG and Thermo Fisher Scientific Inc. are the major companies operating in the Bioreactor Market.

Which is the fastest growing region in Bioreactor Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Bioreactor Market?

In 2025, the North America accounts for the largest market share in Bioreactor Market.

What years does this Bioreactor Market cover, and what was the market size in 2024?

In 2024, the Bioreactor Market size was estimated at USD 5.28 billion. The report covers the Bioreactor Market historical market size for years: 2021, 2022, 2023 and 2024. The report also forecasts the Bioreactor Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Bioreactors Industry Report

The global bioreactors market is experiencing substantial growth, driven by increasing demands for vaccines, monoclonal antibodies, and efficient drug development processes. Innovations like single-use bioreactors and advanced control systems are boosting production capabilities in the pharmaceutical and biotechnology sectors. This growth is supported by significant R&D investments and government initiatives to improve healthcare solutions.

The market size is expanding, with North America leading this expansion, supporting both pilot-scale and full-scale production needs. The prevalence of chronic diseases emphasizes the need for quick diagnostics and therapies. The shift towards single-use bioreactors, reducing cross-contamination and operational costs, signifies a move towards more flexible and sustainable manufacturing processes.

The industry growth is underscored by the vital role of bioreactors in advancing healthcare and pharmaceuticals. The industry analysis highlights the importance of market trends and market forecast in understanding the future landscape. The industry research provides insights into market leaders and market value, while the industry outlook and market overview offer a comprehensive perspective on current developments.

The global market is segmented by type, usage, scale, control, and geography, with the market report offering detailed market segmentation and market review. The market growth is driven by innovations and increased demand, as detailed in the industry reports. The market predictions and market data emphasize the importance of staying informed about industry statistics and industry trends.

For a detailed analysis, the report example and report pdf provide in-depth information, making it a valuable resource for research companies. This evolving market underscores the importance of industry information and industry sales in shaping the future of bioreactors in the pharmaceutical industry.